Correlation Between 10X Genomics and Heartbeam
Can any of the company-specific risk be diversified away by investing in both 10X Genomics and Heartbeam at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 10X Genomics and Heartbeam into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 10X Genomics and Heartbeam, you can compare the effects of market volatilities on 10X Genomics and Heartbeam and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 10X Genomics with a short position of Heartbeam. Check out your portfolio center. Please also check ongoing floating volatility patterns of 10X Genomics and Heartbeam.
Diversification Opportunities for 10X Genomics and Heartbeam
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 10X and Heartbeam is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding 10X Genomics and Heartbeam in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heartbeam and 10X Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 10X Genomics are associated (or correlated) with Heartbeam. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heartbeam has no effect on the direction of 10X Genomics i.e., 10X Genomics and Heartbeam go up and down completely randomly.
Pair Corralation between 10X Genomics and Heartbeam
Considering the 90-day investment horizon 10X Genomics is expected to under-perform the Heartbeam. But the stock apears to be less risky and, when comparing its historical volatility, 10X Genomics is 1.33 times less risky than Heartbeam. The stock trades about -0.02 of its potential returns per unit of risk. The Heartbeam is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 249.00 in Heartbeam on September 2, 2024 and sell it today you would earn a total of 57.00 from holding Heartbeam or generate 22.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
10X Genomics vs. Heartbeam
Performance |
| Timeline |
| 10X Genomics |
| Heartbeam |
10X Genomics and Heartbeam Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 10X Genomics and Heartbeam
The main advantage of trading using opposite 10X Genomics and Heartbeam positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 10X Genomics position performs unexpectedly, Heartbeam can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heartbeam will offset losses from the drop in Heartbeam's long position.| 10X Genomics vs. Verve Therapeutics | 10X Genomics vs. Beam Therapeutics | 10X Genomics vs. Caribou Biosciences | 10X Genomics vs. Sana Biotechnology |
| Heartbeam vs. FOXO Technologies | Heartbeam vs. EUDA Health Holdings | Heartbeam vs. Nutex Health | Heartbeam vs. Healthcare Triangle |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |